The global market for oxygen therapy and inhalation devices was valued at $1.0 billion in 2014. As analyzed in this detailed new report by LSI, growth in developed markets, such as the U.S., has been profoundly shaped by trends in reimbursement. While cost-containment efforts by providers have threatened product manufacturers' margins, they have also spurred the adoption of technologies that reduce the need for frequent visits and facilitate more flexible lifestyles for patients, trends which will not only have important consequences in developed markets but could alter the competitive landscape in emerging markets. This report examines the global markets for these devices, which include stationary, ambulatory/portable, and transfilling oxygen concentrators; liquid oxygen systems; cylinders; dry powder inhalers; metered dose inhalers; nebulizers; and patient consumables.
Critical Issues Covered in this Report:
• The competitive landscape for these devices in the U.S. and international markets;
• Quantitative factors including pricing, replacement rates, and product sales; and
• Caseloads and other key infrastructure and market metrics.
1. EXECUTIVE SUMMARY 1.1 The United States 1.2 Europe 1.2.1 Asia-Pacific and the Rest-of-the-World 1.3 Competitive Analysis Exhibit 1-1: Global Market Forecast for Oxygen Therapy and Inhalation Devices by Product Type, 2013-2020 Exhibit 1-2: Global Market Forecast for Oxygen Therapy and Inhalation Devices by Region, 2013-2020 Exhibit 1-3: U.S. Market Forecast for Oxygen Therapy and Inhalation Devices by Product Type, 2013-2020 Exhibit 1-4: European Market Forecast for Oxygen Therapy and Inhalation Devices by Product Type, 2013-2020 Exhibit 1-5: AP & ROW Market Forecast for Oxygen Therapy and Inhalation Devices by Product Type, 2013-2020 Exhibit 1-6: Global Supplier Shares in 2013 and 2014 2. OVERVIEW 2.1 Overview of Relevant Conditions and Clinical Uses for Oxygen Therapy and Inhalation Devices 2.2 Oxygen Therapy 2.3 Inhalation Therapy 2.4 Technology Trends 2.5 Geographical Trends Exhibit 2-1: Clinical Conditions Treated with Oxygen Therapy & Inhalation Devices Exhibit 2-2: Overview of Oxygen Therapy Devices and Inhalation Technologies Exhibit 2-3: Major Technology Trends Exhibit 2-4: Key Regional Factors 3. OXYGEN THERAPY AND INHALATION DEVICES 3.1 Oxygen Therapy Devices 3.1.1 Oxygen Therapy Hardware 3.1.1.1 Cylinders and Compressed Gas Devices 3.1.1.2 Liquid Oxygen Systems 3.1.1.3 Oxygen Concentrators 3.1.2 Accessories and Patient Consumables 3.1.3 Products and Suppliers 3.2 Inhalation Devices 3.2.1 Dry Powder Inhalers 3.2.2 Metered Dose Inhalers 3.2.3 Nebulizers 3.2.4 Products and Suppliers Exhibit 3-1: Overview of Oxygen Therapy Devices and Inhalation Technologies Exhibit 3-2: Oxygen Therapy Devices by Type Exhibit 3-3: Oxygen Therapy Devices: Selected Products and Suppliers in 2014 Exhibit 3-4: Inhalation Technologies by Type Exhibit 3-5: Inhalation Devices: Selected Products and Suppliers in 2014 4. OXYGEN THERAPY AND INHALATION DEVICES: GLOBAL MARKET ANALYSIS 4.1 Patient Volumes and Market Forecasts: Oxygen Therapy Devices by Region 4.1.1 The United States 4.1.1.1 Market Analysis 4.1.1.2 Competitive Analysis 4.1.2 Europe 4.1.3 Asia-Pacific and the Rest-of-the-World 4.1.4 Competitive Analysis 4.2 Patient Volumes and Market Forecasts: Inhalation Devices by Region 4.2.1 The United States 4.2.1.1 Market Analysis 4.2.1.2 Competitive Analysis 4.2.2 Europe 4.2.3 Asia-Pacific and the Rest-of-the-World 4.2.4 Competitive Analysis Exhibit 4-1: Global Market Forecast for Oxygen Therapy and Inhalation Devices by Region, 2013-2020 Exhibit 4-2: Global Market Forecast for Oxygen Therapy and Inhalation Devices by Product Type, 2013-2020 Exhibit 4-3: U.S. Market Forecast for Oxygen Therapy Devices, 2013-2020 Exhibit 4-4: U.S. Market Forecast for Oxygen Therapy Devices by Product Type, 2013-2020 Exhibit 4-5: U.S. Market Forecast for Oxygen Concentrators by Product Type, 2013-2020 Exhibit 4-6: U.S. Market Forecast for Stationary Oxygen Concentrators 2013-2020 Exhibit 4-7: U.S. Market Forecast for Ambulatory/Portable Oxygen Concentrators 2013-2020 Exhibit 4-8: U.S. Market Forecast for Transfilling Systems, 2013-2020 Exhibit 4-9: U.S. Market Forecast for Liquid Oxygen Systems, 2013-2020 Exhibit 4-10: U.S. Market Forecast for Oxygen Cylinders, 2013-2020 Exhibit 4-11: U.S. Supplier Shares for Oxygen Therapy Devices in 2013 & 2014 Exhibit 4-12: European Market Forecast for Oxygen Therapy Devices, 2013-2020 Exhibit 4-13: European Market Forecast for Oxygen Therapy Devices by Product Type, 2013-2020 Exhibit 4-14: European Market Forecast for Oxygen Concentrators by Product Type, 2013-2020 Exhibit 4-15: European Market Forecast for Stationary Oxygen Concentrators 2013-2020 Exhibit 4-16: European Market Forecast for Ambulatory/Portable Oxygen Concentrators 2013-2020 Exhibit 4-17: European Market Forecast for Transfilling Systems, 2013-2020 Exhibit 4-18: European Market Forecast for Liquid Oxygen Systems, 2013-2020 Exhibit 4-19: European Market Forecast for Oxygen Cylinders, 2013-2020 Exhibit 4-20: AP & ROW Market Forecast for Oxygen Therapy Devices, 2013-2020 Exhibit 4-21: AP & ROW Market Forecast for Oxygen Therapy Devices by Product Type, 2013-2020 Exhibit 4-22: AP & ROW Market Forecast for Oxygen Concentrators by Product Type, 2013-2020 Exhibit 4-23: AP & ROW Market Forecast for Stationary Oxygen Concentrators 2013-2020 Exhibit 4-24: AP & ROW Market Forecast for Ambulatory/Portable Oxygen Concentrators 2013-2020 Exhibit 4-25: AP & ROW Market Forecast for Transfilling Systems, 2013-2020 Exhibit 4-26: AP & ROW Market Forecast for Liquid Oxygen Systems, 2013-2020 Exhibit 4-27: AP & ROW Market Forecast for Oxygen Cylinders, 2013-2020 Exhibit 4-28: OUS Supplier Shares for Oxygen Therapy Devices in 2013 & 2014 Exhibit 4-29: U.S. Market Forecast for Inhalation Technologies by Type, 2013-2020 Exhibit 4-30: U.S. Market Forecast for Dry Powder Inhalers, 2013-2020 Exhibit 4-31: U.S. Market Forecast for Metered Dose Inhalers, 2013-2020 Exhibit 4-32: U.S. Market Forecast for Nebulizers, 2013-2020 Exhibit 4-33: U.S. Supplier Shares for Inhalation Devices in 2013 & 2014 Exhibit 4-34: European Market Forecast for Inhalation Technologies by Type, 2013-2020 Exhibit 4-35: European Market Forecast for Dry Powder Inhalers, 2013-2020 Exhibit 4-36: European Market Forecast for Metered Dose Inhalers, 2013-2020 Exhibit 4-37: European Market Forecast for Nebulizers, 2013-2020 Exhibit 4-38: AP & ROW Market Forecast for Inhalation Technologies by Type, 2013-2020 Exhibit 4-39: AP & ROW Market Forecast for Dry Powder Inhalers, 2013-2020 Exhibit 4-40: AP & ROW Market Forecast for Metered Dose Inhalers, 2013-2020 Exhibit 4-41: AP & ROW Market Forecast for Nebulizers, 2013-2020 Exhibit 4-42: OUS Supplier Shares for Inhalation Devices in 2013 & 2014 5. COMPANY PROFILES 5.1 CareFusion 5.2 Chart Industries 5.3 DeVilbiss Healthcare 5.4 Inogen 5.5 Invacare 5.6 Monaghan Medical 5.7 Philips Healthcare 5.8 Salter Labs 5.9 Smiths Medical 5.10 Teleflex Medical